Table 2.
The combined impact of AIP and NLR on the odds ratio of incident CVD risk among participants.
| Characteristic | Model I | Model II | Model III | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | p-Value | OR | 95% CI | p-Value | OR | 95% CI | p-Value | |
| Group 1 | 1.0 (Reference) | — | — | 1.0 (Reference) | — | — | 1.0 (Reference) | — | — |
| Group 2 | 1.78 | 1.45, 2.18 | <0.001 | 1.27 | 1.03, 1.58 | 0.027 | 1.19 | 0.92, 1.53 | 0.2 |
| Group 3 | 1.78 | 1.42, 2.23 | <0.001 | 1.57 | 1.23, 2.02 | <0.001 | 1.35 | 1.03, 1.79 | 0.032 |
| Group 4 | 2.83 | 2.25, 3.55 | <0.001 | 1.96 | 1.53, 2.51 | <0.001 | 1.41 | 1.06, 1.87 | 0.018 |
Note: Model I was not adjusted for any other covariates. Model II was adjusted for age, sex, race, educational attainment, and family income–poverty ratio. Model III was adjusted for age, sex, race,educational attainment, and family income–poverty ratio, alcohol intake, smoking status, BMI, WC, urine creatinine, LDL-C, history of diabetes, history of hypertension, FBG, HbA1c%, SBP, DBP, Platelet. HbA1c%, glycated hemoglobin.
Abbreviations: BMI, body mass index; CI, confidence Interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NLR, neutrophil-to-lymphocyte ratio; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; WC, waist circumference.